12 results
Reliability of the Clinician’s Tardive Inventory (CTI)
-
- Journal:
- CNS Spectrums / Volume 28 / Issue 2 / April 2023
- Published online by Cambridge University Press:
- 14 April 2023, p. 219
-
- Article
-
- You have access
- Export citation
Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia
-
- Journal:
- European Psychiatry / Volume 65 / Issue 1 / 2022
- Published online by Cambridge University Press:
- 24 March 2022, e23
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study -- CORRIGENDUM
-
- Journal:
- CNS Spectrums / Volume 27 / Issue 1 / February 2022
- Published online by Cambridge University Press:
- 17 May 2021, p. 129
-
- Article
-
- You have access
- HTML
- Export citation
Safety and Effectiveness of SEP−363856 in Schizophrenia: Results of a 6-Month, Open-Label Extension Study
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 2 / April 2021
- Published online by Cambridge University Press:
- 10 May 2021, pp. 148-149
-
- Article
-
- You have access
- Export citation
Cardiometabolic Safety of Lumateperone (ITI−007): Post Hoc Analyses of Short-Term Randomized Trials and an Open-Label Long-Term Study in Schizophrenia
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 2 / April 2021
- Published online by Cambridge University Press:
- 10 May 2021, p. 152
-
- Article
-
- You have access
- Export citation
Efficacy of Lurasidone in Antipsychotic-Naive vs. Antipsychotic-Exposed Adolescents with Schizophrenia: Post-Hoc Analysis of a Two-Year, Open-Label Study
-
- Journal:
- CNS Spectrums / Volume 26 / Issue 2 / April 2021
- Published online by Cambridge University Press:
- 10 May 2021, p. 147
-
- Article
-
- You have access
- Export citation
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study
-
- Journal:
- CNS Spectrums / Volume 27 / Issue 1 / February 2022
- Published online by Cambridge University Press:
- 20 October 2020, pp. 118-128
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
186 Results From a 12-Month Open-label Safety Study of Lumateperone (ITI-007) in Patients with Stable Symptoms of Schizophrenia
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 317-318
-
- Article
-
- You have access
- Export citation
104 Long-term Efficacy of Lurasidone in Antipsychotic-naïve vs. Antipsychotic-exposed Adolescents with Schizophrenia: Analysis of a Two-Year Study
-
- Journal:
- CNS Spectrums / Volume 25 / Issue 2 / April 2020
- Published online by Cambridge University Press:
- 24 April 2020, pp. 267-268
-
- Article
-
- You have access
- Export citation
Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study
-
- Journal:
- CNS Spectrums / Volume 21 / Issue 5 / October 2016
- Published online by Cambridge University Press:
- 06 April 2016, pp. 393-402
-
- Article
-
- You have access
- Open access
- HTML
- Export citation
Chapter 3 - Energy and Environment
-
-
- Book:
- Global Energy Assessment
- Published online:
- 05 September 2012
- Print publication:
- 27 August 2012, pp 191-254
-
- Chapter
- Export citation
Contributors
-
-
- Book:
- Essential Clinical Anesthesia
- Published online:
- 05 January 2012
- Print publication:
- 11 July 2011, pp xv-xxviii
-
- Chapter
- Export citation